A Phase I dose-escalation study of ATR inhibitor monotherapy with AZD6738 in advanced solid tumors (PATRIOT Part A)

Dillon, MT; Espinasse, A; Ellis, S; Mohammed, K; Grove, LG; McLellan, L; Smith, SA; ... Harrington, KJ; + view all Dillon, MT; Espinasse, A; Ellis, S; Mohammed, K; Grove, LG; McLellan, L; Smith, SA; Ross, G; Adeleke, S; Woo, K; Josephides, E; Spicer, JF; Forster, MD; Harrington, KJ; - view fewer (2017) A Phase I dose-escalation study of ATR inhibitor monotherapy with AZD6738 in advanced solid tumors (PATRIOT Part A). Presented at: Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington, DC. Green open access

https://ift.tt/2oYO2tr